Flubichin methanesulfonate

Drug Profile

Flubichin methanesulfonate

Alternative Names: VUFB 12950

Latest Information Update: 14 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator VUFB
  • Developer Zentiva
  • Class Analgesics; Anti-inflammatories; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 13 Feb 2001 Suspended-Preclinical for Pain in Czech Republic (Unknown route)
  • 16 Oct 1995 A study has been added to the pharmacokinetics and pharmacodynamics sections
  • 21 Aug 1995 No-Development-Reported for Pain in Czech Republic (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top